Ascus Biosciences Finds $46M For Animal Health, Nutrition
MAY 29, 2020
San Diego-based Ascus Biosciences , a developer of feed supplements for animal health and nutrition, said this week that it has raised $46M in a Series B funding round. THe funding was led by Temasek Holdings, and also included Anterra Capital, Formation 8, and Cavallo Ventures (venture capital arm of Wilbur-Ellis), as well as angels. According to Ascus Biosciences, it will use the funding to go towards its customers sales and service teams, new products, as well as its core technology platform.